MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • A progress update on the Critical Path for Parkinson’s consortium’s pre-competitive 3DT initiative

    M. Müller, J. Cosman, J. Adams, R. Badawy, R. Bhatnagar, B. Bloem, C. Carroll, N. Cooray, T. Dam, D. Dexter, M. Dockendorf, R. Dorsey, M. Frasier, L. Garcia-Gancedo, D. Hill, M. Kostrzebski, E. Kunka, M. Lindemann, J. Mammen, M. Meinders, A. Mirelman, G. Roussos, S. Sardar, T. Simuni, R. Speck, G. Stebbins, K. Ward Barowicz, J. Cedarbaum, D. Stephenson (Tucson, USA)

  • A PROSPECTIVE COHORT STUDY OF COGNITIVE IMPAIRMENT AND CORTISOL LEVELS IN PARKINSON’S DISEASE

    N. Soares, G. Pereira, A. Dutra, N. Artigas, J. Krimberg, B. Monticelli, A. Schumacher-Schuh, R. de Almeida, C. Rieder (Porto Alegre, Brazil)

  • A prospective, controlled study of subthalamic stimulation in Parkinson’s disease: quality of life outcome at the 5-year follow-up

    S. Jost, S. Aloui, A. Rizos, K. Ashkan, J. Evans, A. Sauerbier, J. Petry-Schmelzer, A. Gronostay, G. Fink, M. Barbe, V. Visser-Vandewalle, A. Antonini, M. Silverdale, P. Martinez-Martin, L. Timmermann, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

  • A qualitative study exploring the treatment burden and capacity of people with Parkinson’s and their caregivers

    QY. Tan, H. Roberts, S. Fraser, K. Ibrahim (Southampton, United Kingdom)

  • A randomized clinical trial (RCT) to evaluate the effects of safinamide on apathetic non-demented Parkinson’s disease patients

    J. Kulisevsky, S. Martinez-Horta, A. Campolongo, B. Pascual-Sedano, J. Marin-Lahoz, H. Bejr-Kasem, A. Horta-Barba, A. Puig-Davi, J. Pagonabarraga, I. Aracil-Bolaños, J. Rodriguez-Antiguedad (Barcelona, Spain)

  • A randomized controlled trial comparing the efficacy and safety of pyridostigmine versus midodrine for the treatment of orthostatic hypotension in Parkinson’s disease patients

    C. Limwatthana (Bangkok, Thailand)

  • A randomized, double-blinded crossover trial of short versus conventional pulse width subthalamic deep brain stimulation in Parkinson’s Disease

    JN. Petry-Schmelzer, L. Schwarz, H. Jergas, P. Reker, J. Steffen, H. Dafsari, J. Baldermann, G. Fink, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

  • A randomized, sham-controlled, crossover trial on Transcranial pulsed current stimulation (tPCS) in Huntington disease

    M. Tuesta Bernaola, Y. Tamilselvam, Y. Mahdi, J. Ganguly, D. Aur, M. Jog (London, Canada)

  • A Randomized, Wait-List Controlled Trial of the Feasibility and Efficacy of Small Group Online-based Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease

    N. Nishikawa, T. Hatano, C. Uchida, Y. Ouji, N. Miyamoto, G. Oyama, N. Hattori (Tokyo, Japan)

  • A rare case of Hyperkinetic Movement disorder

    P. A, T. K, S. S, C. P, P. Peter (SALEM, India)

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley